Cocrystal Pharma News - COCP

Company Name	Stock Ticker Symbol	Market	Type
Cocrystal Pharma Inc	COCP	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0349	2.33%	1.5299	16:39:18

Open Price	Low Price	High Price	Close Price	Prev Close
1.48	1.48	1.5999	1.5299	1.495

more quote information »

Recent News

Date	Time	Source	Heading
3/28/2024	08:00	GLOBE	Cocrystal Pharma Reports 2023 Financial Results and Provides..
3/19/2024	08:00	GLOBE	Cocrystal Pharma Receives Pre-IND Responses from the FDA on..
3/01/2024	16:15	EDGAR2	Form 8-K - Current report
1/08/2024	08:00	EDGAR2	Form 8-K - Current report
1/04/2024	16:01	EDGAR2	Form 8-K - Current report
1/04/2024	08:00	GLOBE	Cocrystal Pharma Provides an Update on the Clinical..
1/02/2024	09:53	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/21/2023	17:00	EDGAR2	Form 8-K - Current report
12/06/2023	08:00	EDGAR2	Form 8-K - Current report
12/06/2023	08:00	GLOBE	Cocrystal Pharma Announces First-Patient-In for Phase 2a..
12/04/2023	08:00	EDGAR2	Form 8-K - Current report
11/29/2023	08:00	EDGAR2	Form 8-K - Current report
11/29/2023	08:00	GLOBE	Cocrystal Pharma Highlights its Novel Inhaled and Oral..
11/27/2023	08:00	GLOBE	Cocrystal Pharma to Present at the NobleCon 19 Conference on..
11/13/2023	08:15	EDGAR2	Form 8-K - Current report
11/13/2023	08:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	08:00	GLOBE	Cocrystal Pharma Reports Third Quarter 2023 Financial..
11/09/2023	08:00	GLOBE	Cocrystal Pharma to Discuss Progress with Novel Inhaled and..
10/31/2023	08:00	EDGAR2	Form 8-K - Current report
10/31/2023	08:00	GLOBE	Cocrystal Pharma Receives UK MHRA Authorization to Initiate..
9/28/2023	08:00	GLOBE	Cocrystal Pharma Doses First Subjects in Clinical Study of..
9/05/2023	08:00	GLOBE	Cocrystal Pharma to Participate in the H.C. Wainwright..
8/16/2023	16:05	EDGAR2	Form 8-K - Current report
8/14/2023	08:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	08:00	GLOBE	Cocrystal Pharma Reports Second Quarter 2023 Financial..
8/08/2023	08:00	GLOBE	Cocrystal Pharma Selects Novel Oral Protease Inhibitor..
7/20/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/20/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/20/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/20/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
5/31/2023	08:00	GLOBE	Cocrystal Pharma Receives HREC Approval to Initiate Phase 1..
5/15/2023	08:00	GLOBE	Cocrystal Pharma Reports First Quarter 2023 Financial..
5/04/2023	16:05	GLOBE	Cocrystal Pharma Presents New Data from its CC-42344 Phase 1..
4/24/2023	08:00	GLOBE	Cocrystal Pharma Appoints Pharma Industry Veteran Fred..